mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.6 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.033 |
0.6 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |